{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:57:42Z","timestamp":1781099862716,"version":"3.54.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04166-x","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:47:06Z","timestamp":1776865626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advance in the Kawasaki disease related coronary artery aneurysms: knowledge mapping, trends, and research frontiers"],"prefix":"10.1186","volume":"21","author":[{"given":"Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"4166_CR1","first-page":"178","volume":"16","author":"T Kawasaki","year":"1967","unstructured":"Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi Allergy. 1967;16:178\u2013222.","journal-title":"Arerugi Allergy"},{"key":"4166_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1542\/peds.54.3.271","volume":"54","author":"T Kawasaki","year":"1974","unstructured":"Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271\u20136.","journal-title":"Pediatrics"},{"key":"4166_CR3","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927\u201399. https:\/\/doi.org\/10.1161\/CIR.0000000000000484.","journal-title":"Circulation"},{"key":"4166_CR4","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"P-N Jone","year":"2024","unstructured":"Jone P-N, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y, et al. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation. 2024;150:e481\u2013500. https:\/\/doi.org\/10.1161\/CIR.0000000000001295.","journal-title":"Circulation"},{"key":"4166_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/INF.0000000000002982","volume":"40","author":"RA Maddox","year":"2021","unstructured":"Maddox RA, Person MK, Kennedy JL, Leung J, Abrams JY, Haberling DL, et al. Kawasaki Disease and Kawasaki Disease Shock Syndrome Hospitalization Rates in the United States, 2006\u20132018. Pediatr Infect Dis J. 2021;40:284\u20138. https:\/\/doi.org\/10.1097\/INF.0000000000002982.","journal-title":"Pediatr Infect Dis J"},{"key":"4166_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrrheum.2015.54","volume":"11","author":"ST Shulman","year":"2015","unstructured":"Shulman ST, Rowley AH. Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015;11:475\u201382. https:\/\/doi.org\/10.1038\/nrrheum.2015.54.","journal-title":"Nat Rev Rheumatol"},{"key":"4166_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1253\/jcj.43.633","volume":"43","author":"S Amano","year":"1979","unstructured":"Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J. 1979;43:633\u201343. https:\/\/doi.org\/10.1253\/jcj.43.633.","journal-title":"Jpn Circ J"},{"key":"4166_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1253\/jcj.43.741","volume":"43","author":"S Amano","year":"1979","unstructured":"Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J. 1979;43:741\u20138. https:\/\/doi.org\/10.1253\/jcj.43.741.","journal-title":"Jpn Circ J"},{"key":"4166_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12887-020-02285-5","volume":"20","author":"L-S Chang","year":"2020","unstructured":"Chang L-S, Lin Y-J, Yan J-H, Guo MM-H, Lo M-H, Kuo H-C. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease. BMC Pediatr. 2020;20:398. https:\/\/doi.org\/10.1186\/s12887-020-02285-5.","journal-title":"BMC Pediatr"},{"key":"4166_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341\u20137. https:\/\/doi.org\/10.1056\/NEJM198608073150601.","journal-title":"N Engl J Med"},{"key":"4166_CR11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jpeds.2018.06.034","volume":"202","author":"C Colomba","year":"2018","unstructured":"Colomba C, La Placa S, Saporito L, Corsello G, Ciccia F, Medaglia A, et al. Intestinal Involvement in Kawasaki Disease. J Pediatr. 2018;202:186\u201393. https:\/\/doi.org\/10.1016\/j.jpeds.2018.06.034.","journal-title":"J Pediatr"},{"key":"4166_CR12","first-page":"149","volume":"31","author":"L Masi","year":"2013","unstructured":"Masi L, Franceschelli F, Leoncini G, Gozzini A, Rigante D, La Torre F, et al. Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin Exp Rheumatol. 2013;31:149\u201353.","journal-title":"Clin Exp Rheumatol"},{"key":"4166_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.carpath.2015.02.006","volume":"24","author":"C Shimizu","year":"2015","unstructured":"Shimizu C, Sood A, Lau HD, Oharaseki T, Takahashi K, Krous HF, et al. Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood. Cardiovasc Pathol Off J Soc Cardiovasc Pathol. 2015;24:310\u20136. https:\/\/doi.org\/10.1016\/j.carpath.2015.02.006.","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"key":"4166_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12055-020-01037-5","volume":"37","author":"P Vaswani","year":"2021","unstructured":"Vaswani P, Arora Y, Sahu MK, Velayoudam D. A rare case of Kawasaki disease with giant coronary artery aneurysm. Indian J Thorac Cardiovasc Surg. 2021;37:316\u20139. https:\/\/doi.org\/10.1007\/s12055-020-01037-5.","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"4166_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2025.05.044","author":"Y Ye","year":"2025","unstructured":"Ye Y, Shi Q, Liu F, Jiang N, Zhang W, Mi M, et al. Outcomes of Total Arterial Coronary Artery Bypass Grafting for Kawasaki Disease in Pediatric Patients: A Single-Center Cohort Study. Ann Thorac Surg. 2025. https:\/\/doi.org\/10.1016\/j.athoracsur.2025.05.044.","journal-title":"Ann Thorac Surg"},{"key":"4166_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/S1047951121002420","volume":"32","author":"Y Kwak","year":"2022","unstructured":"Kwak Y, Kwak JG, Cho S, Kim W-H. Long-term clinical outcomes of coronary artery bypass grafting in young children with Kawasaki disease. Cardiol Young. 2022;32:459\u201364. https:\/\/doi.org\/10.1017\/S1047951121002420.","journal-title":"Cardiol Young"},{"key":"4166_CR17","doi-asserted-by":"publisher","first-page":"1017401","DOI":"10.3389\/fimmu.2022.1017401","volume":"13","author":"MA Beckley","year":"2022","unstructured":"Beckley MA, Shrestha S, Singh KK, Portman MA. The role of mitochondria in the pathogenesis of Kawasaki disease. Front Immunol. 2022;13:1017401. https:\/\/doi.org\/10.3389\/fimmu.2022.1017401.","journal-title":"Front Immunol"},{"key":"4166_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41584-024-01119-3","volume":"20","author":"M Noval Rivas","year":"2024","unstructured":"Noval Rivas M, Kocat\u00fcrk B, Franklin BS, Arditi M. Platelets in Kawasaki disease: mediators of vascular inflammation. Nat Rev Rheumatol. 2024;20:459\u201372. https:\/\/doi.org\/10.1038\/s41584-024-01119-3.","journal-title":"Nat Rev Rheumatol"},{"key":"4166_CR19","doi-asserted-by":"publisher","first-page":"2849695","DOI":"10.1155\/2019\/2849695","volume":"2019","author":"Y Liu","year":"2019","unstructured":"Liu Y, Fu L, Pi L, Che D, Xu Y, Zheng H, et al. An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease. Dis Markers. 2019;2019:2849695. https:\/\/doi.org\/10.1155\/2019\/2849695.","journal-title":"Dis Markers"},{"key":"4166_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/ahg.12285","volume":"83","author":"L Pi","year":"2019","unstructured":"Pi L, Xu Y, Fu L, Zhang L, Liu Y, Zhou H, et al. A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease. Ann Hum Genet. 2019;83:54\u201362. https:\/\/doi.org\/10.1111\/ahg.12285.","journal-title":"Ann Hum Genet"},{"key":"4166_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/iub.2015","volume":"71","author":"Y-F Wang","year":"2019","unstructured":"Wang Y-F, Lian X-L, Zhong J-Y, Su S-X, Xu Y-F, Xie X-F, et al. Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm. IUBMB Life. 2019;71:891\u2013900. https:\/\/doi.org\/10.1002\/iub.2015.","journal-title":"IUBMB Life"},{"key":"4166_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.29057\/jbapr.v3i6.6829","volume":"3","author":"K Salinas-R\u00edos","year":"2022","unstructured":"Salinas-R\u00edos K, Garc\u00eda L\u00f3pez AJ. Bibliometrics, a useful tool within the field of research. J Basic Appl Psychol Res. 2022;3:9\u201316. https:\/\/doi.org\/10.29057\/jbapr.v3i6.6829.","journal-title":"J Basic Appl Psychol Res"},{"key":"4166_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/hir.12295","volume":"38","author":"P Kokol","year":"2020","unstructured":"Kokol P, Bla\u017eun Vo\u0161ner H, Zavr\u0161nik J. Application of bibliometrics in medicine: a historical bibliometrics analysis. Health Inf Amp Libr J. 2020;38:125\u201338. https:\/\/doi.org\/10.1111\/hir.12295.","journal-title":"Health Inf Amp Libr J"},{"key":"4166_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"NJ van Eck","year":"2009","unstructured":"van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2009;84:523\u201338. https:\/\/doi.org\/10.1007\/s11192-009-0146-3.","journal-title":"Scientometrics"},{"key":"4166_CR25","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","volume":"11","author":"M Aria","year":"2017","unstructured":"Aria M, Cuccurullo C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017;11:959\u201375. https:\/\/doi.org\/10.1016\/j.joi.2017.08.007.","journal-title":"J Informetr"},{"key":"4166_CR26","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","volume":"57","author":"C Chen","year":"2006","unstructured":"Chen C, CiteSpace II. Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57:359\u201377. https:\/\/doi.org\/10.1002\/asi.20317.","journal-title":"J Am Soc Inf Sci Technol"},{"key":"4166_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1108\/lr-07-2015-0075","volume":"65","author":"M Sedighi","year":"2016","unstructured":"Sedighi M. Application of word co-occurrence analysis method in mapping of the scientific fields (case study: the field of Informetrics). Libr Rev. 2016;65:52\u201364. https:\/\/doi.org\/10.1108\/lr-07-2015-0075.","journal-title":"Libr Rev"},{"key":"4166_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/asi.4630240406","volume":"24","author":"H Small","year":"1973","unstructured":"Small H. Co-citation in the scientific literature: A new measure of the relationship between two documents. J Am Soc Inf Sci. 1973;24:265\u20139. https:\/\/doi.org\/10.1002\/asi.4630240406.","journal-title":"J Am Soc Inf Sci"},{"key":"4166_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004432","author":"X Huang","year":"2025","unstructured":"Huang X, Jin J, Li Y, Zhang Y, Zhang L, Si W, et al. Clinical treatment, research topic and global trends of Kaposiform hemangioendothelioma: a review and bibliometric analysis. Int J Surg Lond Engl. 2025. https:\/\/doi.org\/10.1097\/JS9.0000000000004432.","journal-title":"Int J Surg Lond Engl"},{"key":"4166_CR30","doi-asserted-by":"publisher","first-page":"1020231","DOI":"10.3389\/fpubh.2022.1020231","volume":"10","author":"F Luo","year":"2022","unstructured":"Luo F, Li Y, Zhang Y, Song Y, Diao J. Bibliometric analysis of IgA vasculitis nephritis in children from 2000 to 2022. Front Public Health. 2022;10:1020231. https:\/\/doi.org\/10.3389\/fpubh.2022.1020231.","journal-title":"Front Public Health"},{"key":"4166_CR31","doi-asserted-by":"publisher","first-page":"e29680","DOI":"10.1016\/j.heliyon.2024.e29680","volume":"10","author":"M Li","year":"2024","unstructured":"Li M, Zheng Z, Yi Q. The landscape of hot topics and research frontiers in Kawasaki disease: Scientometric analysis. Heliyon. 2024;10:e29680. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29680.","journal-title":"Heliyon"},{"key":"4166_CR32","doi-asserted-by":"publisher","first-page":"1075659","DOI":"10.3389\/fpubh.2022.1075659","volume":"10","author":"W Tan","year":"2022","unstructured":"Tan W, Jing L, Wang Y, Li W. A global bibliometric analysis on Kawasaki disease research over the last 5 years (2017\u20132021). Front Public Health. 2022;10:1075659. https:\/\/doi.org\/10.3389\/fpubh.2022.1075659.","journal-title":"Front Public Health"},{"key":"4166_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11192-015-1765-5","volume":"106","author":"P Mongeon","year":"2016","unstructured":"Mongeon P, Paul-Hus A. The journal coverage of Web of Science and Scopus: a comparative analysis. Scientometrics. 2016;106:213\u201328. https:\/\/doi.org\/10.1007\/s11192-015-1765-5.","journal-title":"Scientometrics"},{"key":"4166_CR34","doi-asserted-by":"publisher","unstructured":"Ezugwu AE, Oyelade ON, Ikotun AM, Agushaka JO, Ho Y-S. Machine Learning Research Trends in Africa: A 30 Years Overview with Bibliometric Analysis Review. Arch Comput Methods Eng State Art Rev. 2023;1\u201331. https:\/\/doi.org\/10.1007\/s11831-023-09930-z.","DOI":"10.1007\/s11831-023-09930-z"},{"issue":"1 Suppl 1","key":"4166_CR35","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","volume":"101","author":"C Chen","year":"2004","unstructured":"Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004;101(1 Suppl 1):5303\u201310. https:\/\/doi.org\/10.1073\/pnas.0307513100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4166_CR36","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/S0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Lond Engl. 2014;383:1731\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(13)62298-9.","journal-title":"Lancet Lond Engl"},{"key":"4166_CR37","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S2352-4642(21)00270-4","volume":"5","author":"JC Burns","year":"2021","unstructured":"Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021;5:852\u201361. https:\/\/doi.org\/10.1016\/S2352-4642(21)00270-4.","journal-title":"Lancet Child Adolesc Health"},{"key":"4166_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/016555158501000406","volume":"10","author":"SC Bradford","year":"1985","unstructured":"Bradford SC. Sources of information on specific subjects. J Inf Sci. 1985;10:173\u201380. https:\/\/doi.org\/10.1177\/016555158501000406.","journal-title":"J Inf Sci"},{"key":"4166_CR39","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/224953a0","volume":"224","author":"BC Brookes","year":"1969","unstructured":"Brookes BC. Bradford\u2019s law and the bibliography of science. Nature. 1969;224:953\u20136. https:\/\/doi.org\/10.1038\/224953a0.","journal-title":"Nature"},{"key":"4166_CR40","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, et al. JCS\/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease. Circ J Off J Jpn Circ Soc. 2020;84:1348\u2013407. https:\/\/doi.org\/10.1253\/circj.CJ-19-1094.","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"4166_CR41","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","volume":"67","author":"JW Newburger","year":"2016","unstructured":"Newburger JW, Takahashi M, Burns JC, Kawasaki Disease. J Am Coll Cardiol. 2016;67:1738\u201349. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.073.","journal-title":"J Am Coll Cardiol"},{"key":"4166_CR42","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","volume":"110","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747\u201371. https:\/\/doi.org\/10.1161\/01.CIR.0000145143.19711.78.","journal-title":"Circulation"},{"key":"4166_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1258\/vasc.2011.201202","volume":"20","author":"SA Siefert","year":"2012","unstructured":"Siefert SA, Sarkar R. Matrix metalloproteinases in vascular physiology and disease. Vascular. 2012;20:210\u20136. https:\/\/doi.org\/10.1258\/vasc.2011.201202.","journal-title":"Vascular"},{"key":"4166_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13052-025-01990-0","volume":"51","author":"Y Li","year":"2025","unstructured":"Li Y, Lin Y, Shen C, Zhang J, Wang H, Zhang Q, et al. Dynamic changes of serum matrix metalloproteinases and tissue inhibitors in Kawasaki disease: implications for coronary artery lesions persistence. Ital J Pediatr. 2025;51:169. https:\/\/doi.org\/10.1186\/s13052-025-01990-0.","journal-title":"Ital J Pediatr"},{"key":"4166_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas M, Arditi M. Kawasaki disease: pathophysiology and insights from mouse models. Nat Rev Rheumatol. 2020;16:391\u2013405. https:\/\/doi.org\/10.1038\/s41584-020-0426-0.","journal-title":"Nat Rev Rheumatol"},{"key":"4166_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jim-2020-001281","volume":"69","author":"L Wang","year":"2021","unstructured":"Wang L, Yang Y, Cui Q, Cui Y, Li Q, Che X, et al. Evaluating the added predictive ability of MMP-9 in serum for Kawasaki disease with coronary artery lesions. J Investig Med Off Publ Am Fed Clin Res. 2021;69:13\u20139. https:\/\/doi.org\/10.1136\/jim-2020-001281.","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"4166_CR47","doi-asserted-by":"publisher","first-page":"106948","DOI":"10.1016\/j.imlet.2024.106948","volume":"271","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zeng A, Yang P, Zhang J, Liu D, Li M, et al. Role of leukocyte-associated Ig-like receptor-1 in the pathogenesis of Kawasaki disease and coronary artery aneurysms. Immunol Lett. 2025;271:106948. https:\/\/doi.org\/10.1016\/j.imlet.2024.106948.","journal-title":"Immunol Lett"},{"key":"4166_CR48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/art.40784","volume":"71","author":"G Armaroli","year":"2019","unstructured":"Armaroli G, Verweyen E, Pretzer C, Kessel K, Hirono K, Ichida F, et al. Monocyte-Derived Interleukin-1\u03b2 As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease. Arthritis Rheumatol Hoboken NJ. 2019;71:792\u2013804. https:\/\/doi.org\/10.1002\/art.40784.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4166_CR49","doi-asserted-by":"publisher","first-page":"624802","DOI":"10.3389\/fimmu.2021.624802","volume":"12","author":"T Kitoh","year":"2021","unstructured":"Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, et al. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease. Front Immunol. 2021;12:624802. https:\/\/doi.org\/10.3389\/fimmu.2021.624802.","journal-title":"Front Immunol"},{"key":"4166_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/art.41481","volume":"73","author":"I Kon\u00e9-Paut","year":"2021","unstructured":"Kon\u00e9-Paut I, Tellier S, Belot A, Brochard K, Guitton C, Marie I, et al. Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease. Arthritis Rheumatol Hoboken NJ. 2021;73:151\u201361. https:\/\/doi.org\/10.1002\/art.41481.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4166_CR51","doi-asserted-by":"publisher","first-page":"114479","DOI":"10.1016\/j.jpeds.2025.114479","volume":"279","author":"I Bellicini","year":"2025","unstructured":"Bellicini I, Bainto E, Shimizu C, Burns JC, Tremoulet AH. Cyclosporine Treatment in Patients with Kawasaki Disease and Coronary Artery Aneurysms or Treatment Resistance. J Pediatr. 2025;279:114479. https:\/\/doi.org\/10.1016\/j.jpeds.2025.114479.","journal-title":"J Pediatr"},{"key":"4166_CR52","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12519-016-0023-0","volume":"12","author":"H Zhang","year":"2016","unstructured":"Zhang H, Xu M-G, Xie L-J, Huang M, Shen J, Xiao T-T. Meta-analysis of risk factors associated with atherosclerosis in patients with Kawasaki disease. World J Pediatr WJP. 2016;12:308\u201313. https:\/\/doi.org\/10.1007\/s12519-016-0023-0.","journal-title":"World J Pediatr WJP"},{"key":"4166_CR53","doi-asserted-by":"publisher","first-page":"e180030","DOI":"10.1001\/jamapediatrics.2018.0030","volume":"172","author":"M Miura","year":"2018","unstructured":"Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, et al. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events. JAMA Pediatr. 2018;172:e180030. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0030.","journal-title":"JAMA Pediatr"},{"key":"4166_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ahj.2013.10.025","volume":"167","author":"E Tsuda","year":"2014","unstructured":"Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, et al. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J. 2014;167:249\u201358. https:\/\/doi.org\/10.1016\/j.ahj.2013.10.025.","journal-title":"Am Heart J"},{"key":"4166_CR55","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpeds.2020.02.033","volume":"221","author":"JC Burns","year":"2020","unstructured":"Burns JC, El-Said H, Tremoulet AH, Friedman K, Gordon JB, Newburger JW. Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease. J Pediatr. 2020;221:230\u20134. https:\/\/doi.org\/10.1016\/j.jpeds.2020.02.033.","journal-title":"J Pediatr"},{"key":"4166_CR56","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1161\/CIR.0000000000001039","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e4\u201317. https:\/\/doi.org\/10.1161\/CIR.0000000000001039.","journal-title":"Circulation"},{"key":"4166_CR57","doi-asserted-by":"publisher","first-page":"e016440","DOI":"10.1161\/JAHA.119.016440","volume":"9","author":"BW McCrindle","year":"2020","unstructured":"McCrindle BW, Manlhiot C, Newburger JW, Harahsheh AS, Giglia TM, Dallaire F, et al. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry. J Am Heart Assoc. 2020;9:e016440. https:\/\/doi.org\/10.1161\/JAHA.119.016440.","journal-title":"J Am Heart Assoc"},{"key":"4166_CR58","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","volume":"395","author":"L Verdoni","year":"2020","unstructured":"Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet Lond Engl. 2020;395:1771\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)31103-X.","journal-title":"Lancet Lond Engl"},{"key":"4166_CR59","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jama.2020.10370","volume":"324","author":"BW McCrindle","year":"2020","unstructured":"McCrindle BW, Manlhiot C. SARS-CoV-2-Related Inflammatory Multisystem Syndrome in Children: Different or Shared Etiology and Pathophysiology as Kawasaki Disease? JAMA. 2020;324:246\u20138. https:\/\/doi.org\/10.1001\/jama.2020.10370.","journal-title":"JAMA"},{"key":"4166_CR60","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1007\/s00392-020-01656-3","volume":"109","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol Off J Ger Card Soc. 2020;109:1446\u201359. https:\/\/doi.org\/10.1007\/s00392-020-01656-3.","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"4166_CR61","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41467-022-30357-w","volume":"13","author":"P Ghosh","year":"2022","unstructured":"Ghosh P, Katkar GD, Shimizu C, Kim J, Khandelwal S, Tremoulet AH, et al. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease. Nat Commun. 2022;13:2687. https:\/\/doi.org\/10.1038\/s41467-022-30357-w.","journal-title":"Nat Commun"},{"key":"4166_CR62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41584-022-00820-5","volume":"18","author":"P Tsoukas","year":"2022","unstructured":"Tsoukas P, Yeung RSM. Kawasaki disease and MIS-C share a host immune response. Nat Rev Rheumatol. 2022;18:555\u20136. https:\/\/doi.org\/10.1038\/s41584-022-00820-5.","journal-title":"Nat Rev Rheumatol"},{"key":"4166_CR63","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/art.42680","volume":"76","author":"KE Brodeur","year":"2024","unstructured":"Brodeur KE, Liu M, Ibanez D, de Groot MJ, Chen L, Du Y, et al. Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders. Arthritis Rheumatol Hoboken NJ. 2024;76:285\u201392. https:\/\/doi.org\/10.1002\/art.42680.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4166_CR64","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/covid3030026","volume":"3","author":"I Osoro","year":"2023","unstructured":"Osoro I, Vohra M, Amir M, Kumar P, Sharma A. A Scoping Review on COVID-19-Induced Cardiovascular Complications. COVID. 2023;3:348\u201369. https:\/\/doi.org\/10.3390\/covid3030026.","journal-title":"COVID"},{"key":"4166_CR65","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","volume":"383","author":"LR Feldstein","year":"2020","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383:334\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2021680.","journal-title":"N Engl J Med"},{"key":"4166_CR66","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1001\/jama.2021.2091","volume":"325","author":"LR Feldstein","year":"2021","unstructured":"Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325:1074\u201387. https:\/\/doi.org\/10.1001\/jama.2021.2091.","journal-title":"JAMA"},{"key":"4166_CR67","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/art.42062","volume":"74","author":"LA Henderson","year":"2022","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3. Arthritis Rheumatol Hoboken NJ. 2022;74:e1\u201320. https:\/\/doi.org\/10.1002\/art.42062.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4166_CR68","doi-asserted-by":"publisher","unstructured":"Tai I-H, Hsieh K-S, Kuo H-C. Beaded Coronary Aneurysm in Kawasaki Disease. Child Basel Switz. 2022;9. https:\/\/doi.org\/10.3390\/children9101463.","DOI":"10.3390\/children9101463"},{"key":"4166_CR69","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaccas.2022.05.012","volume":"4","author":"H Suzuki","year":"2022","unstructured":"Suzuki H, Kuroko Y, Kotani Y, Sakoda N, Kasahara S. A Ruptured Coronary Artery Aneurysm Secondary to Kawasaki Disease. JACC Case Rep. 2022;4:790\u20133. https:\/\/doi.org\/10.1016\/j.jaccas.2022.05.012.","journal-title":"JACC Case Rep"},{"key":"4166_CR70","doi-asserted-by":"publisher","unstructured":"Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, et al. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. J Am Heart Assoc. 2016;5. https:\/\/doi.org\/10.1161\/JAHA.116.003289.","DOI":"10.1161\/JAHA.116.003289"},{"key":"4166_CR71","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/INF.0000000000002793","volume":"39","author":"GB Kim","year":"2020","unstructured":"Kim GB, Eun LY, Han JW, Kim SH, Yoon KL, Han MY, et al. Epidemiology of Kawasaki Disease in South Korea: A Nationwide Survey 2015\u20132017. Pediatr Infect Dis J. 2020;39:1012\u20136. https:\/\/doi.org\/10.1097\/INF.0000000000002793.","journal-title":"Pediatr Infect Dis J"},{"key":"4166_CR72","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12969-021-00566-6","volume":"19","author":"HS An","year":"2021","unstructured":"An HS, Kim GB, Song MK, Lee SY, Kwon HW, Lee JW, et al. The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study. Pediatr Rheumatol Online J. 2021;19:78. https:\/\/doi.org\/10.1186\/s12969-021-00566-6.","journal-title":"Pediatr Rheumatol Online J"},{"key":"4166_CR73","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/rheumatology\/keaa050","volume":"59","author":"X Jia","year":"2020","unstructured":"Jia X, Du X, Bie S, Li X, Bao Y, Jiang M. What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis. Rheumatol Oxf Engl. 2020;59:1826\u201333. https:\/\/doi.org\/10.1093\/rheumatology\/keaa050.","journal-title":"Rheumatol Oxf Engl"},{"key":"4166_CR74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12969-021-00526-0","volume":"19","author":"O Halyabar","year":"2021","unstructured":"Halyabar O, Friedman KG, Sundel RP, Baker AL, Chang MH, Gould PW, et al. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms. Pediatr Rheumatol Online J. 2021;19:31. https:\/\/doi.org\/10.1186\/s12969-021-00526-0.","journal-title":"Pediatr Rheumatol Online J"},{"key":"4166_CR75","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12887-024-04672-8","volume":"24","author":"B Yu","year":"2024","unstructured":"Yu B, Zheng B, Shen Y, Shen Y, Qiu H, Wu L, et al. NLRC4 methylation and its response to intravenous immunoglobulin therapy in Kawasaki disease: a case control study. BMC Pediatr. 2024;24:190. https:\/\/doi.org\/10.1186\/s12887-024-04672-8.","journal-title":"BMC Pediatr"},{"key":"4166_CR76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13052-021-01041-4","volume":"47","author":"AA Medaglia","year":"2021","unstructured":"Medaglia AA, Siracusa L, Gio\u00e8 C, Giordano S, Cascio A, Colomba C. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital J Pediatr. 2021;47:95. https:\/\/doi.org\/10.1186\/s13052-021-01041-4.","journal-title":"Ital J Pediatr"},{"key":"4166_CR77","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12519-021-00435-y","volume":"17","author":"Q-Y Zhang","year":"2021","unstructured":"Zhang Q-Y, Xu B-W, Du J-B. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment. World J Pediatr WJP. 2021;17:335\u201340. https:\/\/doi.org\/10.1007\/s12519-021-00435-y.","journal-title":"World J Pediatr WJP"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04166-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04166-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T13:03:23Z","timestamp":1781096603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04166-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4166"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04166-x","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}